RecruitingNot Applicable

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants

France500 participantsStarted 2020-10-21

Plain-language summary

This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient receiving a comprehensive information about the study, and not opposed to participate * Age ≥ 18 yo * Classification of definite APS according to revised Sapporo-Sydney criteria * Direct oral anticoagulant treatment prescribed during at least 6 months or with the possibility of follow-up of at least 6 months Exclusion Criteria: * Incomplete revised Sapporo-Sydney criteria * No data regarding the recurrent thrombosis * Pregnant woman * Age \< 18 yo

What they're measuring

Rate of Recurrent Thrombosis

Timeframe: 6 months

Trial details

NCT IDNCT04262492

SponsorStéphane Zuily

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-04-21

Contact for this trial

Virginie Dufrost, MD, MSc

+33383157828 v.dufrost@chru-nancy.Fr

View on ClinicalTrials.gov More Antiphospholipid Syndrome trials